Fromer Eye Centers Settles $2.3 Million Healthcare Fraud Allegations
Fromer Eye Centers settles a $2.3 million case under the False Claims Act for improper billing. Explore the implications for healthcare compliance and fraud prevention.
Congress Urges Reevaluation of Medicare Cuts for Skin Cancer Therapy
Congress demands CMS reconsider Medicare cuts on skin cancer therapy, ensuring patient access and affordability in healthcare amid ongoing debates.
Medicare Part D Changes: Impacts on Seniors and Premiums
Anticipate changes to Medicare Part D that may raise prescription costs for seniors. Learn how these revisions could affect your premiums and budget.
61st Anniversary of Medicare and Medicaid: A Commitment to Rhode Island's Healthcare
A landmark event in Coventry highlights Medicare and Medicaid's role in Rhode Island. Officials advocate for accessible healthcare amid rising costs.
Legislative Changes Impacting Medicaid and Medicare: A Call to Action
Explore the impact of recent legislative changes on Medicaid and Medicare, focusing on advocacy for vulnerable populations and the importance of healthcare programs.
2027 Updates on Medicare Payment Structures and Rates
Explore CMS's finalized Medicare updates for 2027, enhancing payment structures and rates across skilled nursing and psychiatric facilities, ensuring compliance.
Significant Medicare Part D Subsidy Changes Impacting Premiums and Drug Costs
Learn about the recent Medicare Part D subsidies change, its effects on premiums and drug pricing. Understand how this impacts beneficiaries and insurance markets.
Understanding Medicare: Free Seminar at East Hills Library
Join us for a free 'Medicare 101' seminar on August 10. Learn the essentials of Medicare and Medicaid programs for informed healthcare choices.
Impact of Ending Medicare Part D Subsidies on Prescription Costs
The termination of Medicare Part D subsidies will impact millions of seniors, raising prescription costs. Learn more about the implications and future changes.
Proposed Changes to 340B Drug Program Impacting Medicare Reimbursements
CMS proposes changes to 340B drug program reimbursement impacting Medicare rates. Explore the implications for hospitals and patients in 2027.